To The Stars and the ADAM Research Project: four years, an Army agreement and not a single paper
The only investigation of anomalous materials with audited, accessible accounts. You can follow the money, the agreement and the outcome: nothing was published.
To The Stars Academy of Arts & Science launched in October 2017 as a company funded through a public share offering, which obliged it to file audited accounts. Its ADAM program was meant to acquire and analyze materials of anomalous provenance and publish the results. In 2019 it acquired the fragments known as Art's Parts and, that same year, signed a research cooperation agreement with a U.S. Army center. In about four years it published no peer-reviewed article or reproducible technical report, and the science arm was dismantled when the company redirected itself toward entertainment.
Executive summary of the case file. Everything essential before you dig deeper.
Fact sheet
OSINT - Traceability
Friends, today I bring you a case file that gets investigated in an unromantic place: the records of the U.S. securities regulator. No deserts, no hangars, no sources with distorted voices: forms, annual accounts, auditor footnotes. That office perfume that, when it shows up, usually means one of two things: either someone wants to regulate something… or someone has to account for where the money went.
Because that is what makes To The Stars peculiar, and the reason this case is so strange and so useful. When Tom DeLonge presented his academy in October 2017 with a cast that included former senior intelligence officials and prestigious physicists, he did not set up a foundation or an association of researchers. He set up a company that sold shares to the public. And a company that sells shares to the public has to file paperwork.
That makes To The Stars the only anomalous-materials research project for which audited, accessible accounts exist. In this trade, where the norm is the claim without an invoice, having access to someone’s books is a luxury. Let’s use it.
What can be verified, first
The company existed and its paperwork is public. It was set up as a corporation that raised capital from small investors through a simplified form of public offering, which obliged it to file its annual accounts with the U.S. regulator. Those documents are still there, and in them appear the things that usually appear in the accounts of a young company that spends more than it earns: accumulated operating losses and the auditor’s warnings about the company’s ability to continue as a going concern.
The materials program was announced under its own name: ADAM, an English-language acronym for acquisition and analysis of materials data. Its declared purpose was to obtain samples of anomalous provenance and subject them to characterization in qualified laboratories, publishing the results. That word, publishing, is the one to underline and the one to go looking for at the end of the file.
In 2019 the program announced its most talked-about acquisition: the so-called Art’s Parts, the layered bismuth and magnesium fragments that had been circulating since 1996 with an anonymous letter as their only provenance. The purchase was announced as a milestone. From a documentary standpoint, what it did was move an object with no chain of custody from one cupboard to another.
And in October of that same year came the most solid element of the whole story: a cooperative research and development agreement with a U.S. Army ground systems center. It is an administrative instrument with a name, and the Army confirmed it publicly. Its purpose was to study metamaterials and other lines with possible applications in vehicle protection and power systems.
Here we have to be precise, because this is the point where almost all coverage goes off the rails. An agreement of that kind is not a grant or a scientific endorsement but a framework under which a public institution and a private entity agree to collaborate and share facilities or results, normally with no transfer of funds from the former to the latter. Signing it means the Army agreed to look. It does not mean the Army bought the premise.
Launch
Tom DeLonge presents To The Stars with a team of former intelligence and defense officials and a funding model based on a public share offering.
The videos
The company appears in the coverage that brings to light the Pentagon program and the Navy videos. It is its moment of maximum visibility.
ADAM
The materials acquisition and analysis program is announced, with the declared commitment to publish the results.
The purchase
The program acquires the layered fragments known as Art's Parts, whose provenance is an anonymous letter from 1996.
The agreement
A research cooperation agreement is signed with a U.S. Army center to study metamaterials. The Army confirms it publicly.
Departures
Luis Elizondo and Christopher Mellon leave the company.
Retreat
The company redirects its activity toward entertainment and dismantles its science arm without having published results in peer-reviewed literature.
The outcome, which is the part nobody tells
Let’s go to the end, because the end is the data point. Between the announcement of the program and its dismantling, roughly four years passed. In that time not a single peer-reviewed journal article appeared, signed by the program and referring to the acquired materials. Not one. Nor was there a public technical report with methodology, laboratory, instrumentation and results that another group could try to reproduce.
What there were, were presentations, press releases and appearances. That is: the communication channel ran at full capacity while the verification channel stayed closed. And that imbalance, in an organization created precisely to reverse it, is the finding of this case file.
In 2021 the two figures who gave the company institutional credibility in Washington left. The following year the company redirected its activity toward entertainment (content, series, publications) and its science arm ceased to exist in practice. The materials, as far as the public record shows, have produced no published characterization.
It is worth saying what this is not being compared with. Nobody is being asked to prove the impossible in four years. They are being asked to publish what they measured, whatever it is. A paper that said “we have analyzed these samples, the composition is this, the isotopic ratios are terrestrial and we found no anomaly” would have been a perfectly valuable and perfectly honorable result. Not even that was published.
What it could be, with no need for a conspiracy
A young company that runs out of money
The most boring explanation and the one that best fits the paperwork. Investigating materials seriously is expensive: electron microscopy, isotope-ratio mass spectrometry, instrument time in accredited laboratories, qualified staff. A company with recurring losses and going-concern warnings is in no position to sustain a program like that, least of all when its other line of business (content) has a faster return. You don’t need a dark back office to explain a shutdown: an income statement is enough.
That there was nothing to publish
The second, just as simple. If the samples were analyzed and came out terrestrial and ordinary, publishing the result would have been scientifically correct and commercially dreadful for a company whose market value depended on expectation. I am not claiming that this is what happened, because nothing on record says so; I am pointing out that the incentive pointed in that direction and that the silence is compatible with that scenario as much as with any other.
That science is slow
And the third has to be conceded, in fairness. Rigorous characterization of materials takes time, peer review takes longer, and four years with a pandemic in the middle is not a scandalous timeframe. The problem is the combination of the silence with the dismantling of the program and with the absence of any interim report.
Why this case matters more than it seems
Because To The Stars is one of the central pieces of the contemporary conversation. The December 2017 coverage that brought to light the Pentagon program and the three Navy videos passed through its orbit, and several of the people who have since appeared before the U.S. Congress were on its payroll. What this company did and failed to do conditions how everything else is read.
And because it sets a yardstick that strikes me as the most useful there is. When someone announces they have anomalous material, the question is no longer “will you show it to me?” The question is: where is the paper? Which laboratory? Which instrument? What result, even a negative one? Because an organization funded by small public investors, with prestigious physicists and an agreement with the Army, had four years to answer that and did not.
Fairness also requires acknowledging the other side. To The Stars genuinely pushed a debate that was stalled, and the fact that today there is a Department of Defense office devoted to the subject, and congressional hearings, has something to do with that push. One can hold at once that the push was useful and that the materials program delivered nothing. Both things are in the same public record.
For contrast, there is the historical report from the Pentagon office, which did publish its work, with its sources, its limits and its debatable conclusions. And there is the case file on Elizondo’s departure, which resolves in exactly the same way: by looking at the paperwork instead of listening to the story.
What would have counted as a result
So that this case file is not read as a settling of scores, it is worth putting in writing what would have been needed. None of it is impossible or especially expensive compared with what the company spent on communication.
A technical report with the sample identified by a code, the chain of custody documented from the moment of acquisition, the laboratory and instrument used, the preparation methodology, the results with their uncertainties and the raw data available to anyone who wanted to reanalyze them. That is a standard deliverable in materials science, what gets signed in any characterization contract.
And above all, the published isotopic analysis. It is the only measurement that separates a terrestrial origin from one that is not, it costs what an afternoon of spectrometer time costs, and its result, whatever it was, would have been news. That not even this was published is the central data point of the case file.
It is also worth pointing out what does not count, because it is what abounded. A presentation with micrographs lacking scale or provenance does not count. A passing remark in an interview that the results are surprising does not count. A corporate press release does not count. And the signing of an agreement certainly does not count: an agreement is a permit to work, not work.
There is one last consideration that seems to me the most important, and it has to do with who put up the money. This company was funded by contributions from thousands of small private investors who bought shares convinced that something was being investigated. Those people were entitled to a report. The absence of published results is a scientific deficit and also an accountability deficit toward specific people who paid for them.
And that is why this case, which looks like the most bureaucratic in the sector, is at bottom the most exemplary. Here you don’t have to believe anyone or distrust anyone. You have to read the accounts, look for the paper and check that it isn’t there. The method is within anyone’s reach and needs no anonymous source.
I keep the image of the whole case file: an object that arrived by mail in 1996, under a pseudonym and with no return address, and that twenty-three years later ends up mentioned in the same paragraph as a U.S. Army agreement. The object did not change. The letterhead did. And a letterhead, however good, is not a chain of custody.
OSINT – Source traceability
Specific figures for losses or capital raised are not reproduced: they vary between fiscal years and citing a single one would give a false picture. The nature of the auditor's warnings is described, not their exact wording. No intentions are attributed to the company or its principals: what is on record as published, and what is not, is described.